Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Lawsuit - BIIB
04:20am, Thursday, 13'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 13, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
04:20pm, Wednesday, 12'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit.
RADNOR, PA / ACCESSWIRE / June 12, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States
Biogen Inc. (BIIB) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
02:20pm, Wednesday, 12'th Jun 2024
Biogen Inc. (NASDAQ:BIIB ) Goldman Sachs 45th Annual Global Healthcare Conference June 12, 2024 10:40 AM ET Company Participants Alisha Alaimo - Head and President of North-America Chuck Triano - Head
July 22, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BIIB
12:15pm, Wednesday, 12'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
12:00pm, Wednesday, 12'th Jun 2024
BENSALEM, Pa. , June 12, 2024 /PRNewswire/ -- Law Offices of Howard G.
Biogen executive says its Alzheimer's drug will do well in market despite competition
11:59am, Wednesday, 12'th Jun 2024
Biogen's Alzheimer's drug, Leqembi, will do well in the market, whether a competitor will come or not, a company executive said at the Goldman Sachs Global Healthcare Conference on Wednesday.
Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BIIB
07:20am, Wednesday, 12'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
05:15am, Wednesday, 12'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit!
05:00am, Wednesday, 12'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bi
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
03:45pm, Tuesday, 11'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit.
